Original Article
Does selected immunological panel possess the value of predicting the prognosis of early-stage resectable non-small cell lung cancer?
Translational Lung Cancer Research
2019;
8
(5)
:559-574
.
(29 October 2019)
The impact of previous therapy strategy on the efficiency of anlotinib hydrochloride as a third-line treatment on patients with advanced non-small cell lung cancer (NSCLC): a subgroup analysis of ALTER0303 trial
Translational Lung Cancer Research
2019;
8
(5)
:575-583
.
(29 October 2019)
EGFR T790M detection rate in lung adenocarcinomas at baseline using droplet digital PCR and validation by ultra-deep next generation sequencing
Translational Lung Cancer Research
2019;
8
(5)
:584-592
.
(29 October 2019)
Survival score to characterize prognosis in inoperable stage III NSCLC after chemoradiotherapy
Translational Lung Cancer Research
2019;
8
(5)
:593-604
.
(29 October 2019)
Comparison of Veterans Affairs, Mayo, Brock classification models and radiologist diagnosis for classifying the malignancy of pulmonary nodules in Chinese clinical population
Translational Lung Cancer Research
2019;
8
(5)
:605-613
.
(29 October 2019)
Systematic analysis identifies three-lncRNA signature as a potentially prognostic biomarker for lung squamous cell carcinoma using bioinformatics strategy
Translational Lung Cancer Research
2019;
8
(5)
:614-635
.
(29 October 2019)
Validation of a serum 4-microRNA signature for the detection of lung cancer
Translational Lung Cancer Research
2019;
8
(5)
:636-648
.
(29 October 2019)
Synchronous multiple lung cancers presenting as multifocal pure ground glass nodules: are whole-body positron emission tomography/computed tomography and brain enhanced magnetic resonance imaging necessary?
Translational Lung Cancer Research
2019;
8
(5)
:649-657
.
(29 October 2019)
Management of the inter-segmental plane using the “Combined Dimensional Reduction Method” is safe and viable in uniport video-assisted thoracoscopic pulmonary segmentectomy
Translational Lung Cancer Research
2019;
8
(5)
:658-666
.
(29 October 2019)
Targeting PKCι-PAK1 in EGFR-mutation positive non-small cell lung cancer
Translational Lung Cancer Research
2019;
8
(5)
:667-673
.
(29 October 2019)
Prognostic roles of the expression of sphingosine-1-phosphate metabolism enzymes in non-small cell lung cancer
Translational Lung Cancer Research
2019;
8
(5)
:674-681
.
(29 October 2019)
Brain metastases from lung cancer with neuropsychiatric symptoms as the first symptoms
Translational Lung Cancer Research
2019;
8
(5)
:682-691
.
(29 October 2019)
Review Article
Current perspectives on statins as potential anti-cancer therapeutics: clinical outcomes and underlying molecular mechanisms
Translational Lung Cancer Research
2019;
8
(5)
:692-699
.
(29 October 2019)
Case Report
Primary pleural epithelioid sarcoma of the proximal type: a diagnostic and therapeutic challenge
Translational Lung Cancer Research
2019;
8
(5)
:700-705
.
(29 October 2019)
Editorial Commentary
KEYNOTE-021 cohorts D and H suggest modest benefit in combining ipilimumab with pembrolizumab in second-line or later advanced non-small cell lung cancer treatment
Translational Lung Cancer Research
2019;
8
(5)
:706-709
.
(29 October 2019)
Immunotherapy in EGFR mutant non-small cell lung cancer: when, who and how?
Translational Lung Cancer Research
2019;
8
(5)
:710-714
.
(29 October 2019)
Can PD-L1 tumor proportion score be used as the key to unlocking the KEYNOTE studies of pembrolizumab in advanced lung cancer?
Translational Lung Cancer Research
2019;
8
(5)
:715-722
.
(29 October 2019)
KEYNOTE-042: is lowering the PD-L1 threshold for first-line pembrolizumab monotherapy a good idea?
Translational Lung Cancer Research
2019;
8
(5)
:723-727
.
(29 October 2019)
First-line immunotherapy for patients with advanced stage or metastatic non-small cell lung cancer…finally what threshold of PD-L1 expression on tumor cells?
Translational Lung Cancer Research
2019;
8
(5)
:728-730
.
(29 October 2019)
The KEY to the end of the chemotherapy in advanced non-small cell lung cancer, or not yet?
Translational Lung Cancer Research
2019;
8
(5)
:731-737
.
(29 October 2019)
